ODOMZO is a hedgehog pathway inhibitor indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.<\/p>\n
If sonidegib capsules are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n","protected":false},"excerpt":{"rendered":"
Odomzo (sonidegib) is a medication for the treatment of locally advanced basal cell carcinoma (BCC) that cannot be treated with surgery or radiation therapy.<\/p>\n
DISEASE INDICATIONS-Skin Cancer If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201csonidegib capsules\u201d based on the information you provide.<\/p>\n
\nMANUFACTURER-Sun Pharmaceutical Industries Europe B.V.
\nUSAGE-Oral
\nMEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Therapeutic Goods Administration (TGA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n